Catalyst Wire Dossier Catalyst Wire Dossier

Danoprevir/ritonavir

danoprevir/ritonavir · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Danoprevir/ritonavir, covering 2016-11-02 to 2020-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection [Phase 4]

See pricing